Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

300 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
Reijneveld JC, Taphoorn MJB, Coens C, Bromberg JEC, Mason WP, Hoang-Xuan K, Ryan G, Hassel MB, Enting RH, Brandes AA, Wick A, Chinot O, Reni M, Kantor G, Thiessen B, Klein M, Verger E, Borchers C, Hau P, Back M, Smits A, Golfinopoulos V, Gorlia T, Bottomley A, Stupp R, Baumert BG. Reijneveld JC, et al. Among authors: bottomley a. Lancet Oncol. 2016 Nov;17(11):1533-1542. doi: 10.1016/S1470-2045(16)30305-9. Epub 2016 Sep 27. Lancet Oncol. 2016. PMID: 27686943 Clinical Trial.
The cancer patient and quality of life.
Bottomley A. Bottomley A. Oncologist. 2002;7(2):120-5. doi: 10.1634/theoncologist.7-2-120. Oncologist. 2002. PMID: 11961195 Free article. Review.
Erythropoietin improves quality of life--a response.
Bottomley A, Thomas R, Van Steen K, Flechtner H, Djulbegovic B. Bottomley A, et al. Lancet Oncol. 2002 Sep;3(9):527. doi: 10.1016/s1470-2045(02)00844-6. Lancet Oncol. 2002. PMID: 12217788 No abstract available.
Assessing HRQOL: a neglected issue for high-grade glioma.
Efficace F, Bottomley A. Efficace F, et al. Among authors: bottomley a. Lancet Oncol. 2003 Jan;4(1):11-2. doi: 10.1016/s1470-2045(03)00955-0. Lancet Oncol. 2003. PMID: 12517534 No abstract available.
Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials--does HRQOL evaluation in prostate cancer research inform clinical decision making?
Efficace F, Bottomley A, Osoba D, Gotay C, Flechtner H, D'haese S, Zurlo A. Efficace F, et al. Among authors: bottomley a. J Clin Oncol. 2003 Sep 15;21(18):3502-11. doi: 10.1200/JCO.2003.12.121. J Clin Oncol. 2003. PMID: 12972527 Clinical Trial.
300 results